DIA 2013 49th Annual Meeting
Click here to go to the previous page
eSource Symposium
Track : Track 11: Innovative Approaches to Ensuring Compliance with Good Clinical Practice (GCP) and Quality Assurance (QA)
Program Code: 409
Date: Thursday, June 27, 2013
Time: 9:00 AM to 10:30 AM  EST
Location: 156AB
CHAIR :
H. Chris Ramm, (SCHNON), Global Director, Sales and Marketing, Clinical Ink, United States
SPEAKER (S):
 Catherine Celingant, MA (SPKNON), Senior Director, Medical Business Operations, Medical Strategy and Operations, Millennium: The Takeda Oncology Company, United States
 Jules Mitchel, PhD,MBA (SPKNON), President, Target Health Inc., United States
Description
The collection and use of eSource clinical data is rapidly becoming the standard medium for clinical research. Regulatory authorities have been increasingly more vocal of their support for the use of eSource clinical data, a fact that may be helping in the continued adoption of eSource and electronic data capture in general during the conduct and assessment of clinical research.

This symposium will introduce risk-based approaches when electronic data are intended to serve as the source of clinical data. Additionally, we will discuss how monitors and data managers can work together when developing and implementing a risk-based monitoring program. A final topic is the assessment of electronic health record systems that will be the repository of eSource data.


Session Recording
(Code: 409)
DIA 2013 Attendee:
  
This session is a part of: